Stay updated on Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial

Sign up to get notified when there's something new on the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T05:08:49.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T23:52:50.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Added Tuberculosis as an item. Introduced a new resources link to the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-02-18T16:31:38.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the funding-status notice and the earlier Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T09:57:15.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Added a government-funding notice about site operations. Updated the page revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T06:53:00.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    Glossary feature added to the page. Metadata labels updated (Last Update Submitted that Met QC Criteria; No FEAR Act Data) and the revision version bumped from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T04:48:39.000Z thumbnail image

Stay in the know with updates to Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page.